Yu Guo

发表

ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream from transcription start sites at the majority of CpG island promoters

P. Farnham, Heather Witt, S. Rhie, 2018, Genome research.

Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits

G. Coetzee, P. Laird, P. Farnham, 2016, Epigenetics & Chromatin.

lncRNA PVT1 promotes hepatitis B virus‑positive liver cancer progression by disturbing histone methylation on the c‑Myc promoter.

W. Lu, Xiaoya Zheng, Bing Yang, 2019, Oncology reports.

Histone acetyltransferase p300 promotes MKL1-mediated transactivation of catechol-O-methyltransferase gene.

Hao Zhou, Wenjian Ma, Xuegang Luo, 2013, Acta biochimica et biophysica Sinica.

CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops

Dennis J. Hazelett, G. Coetzee, P. Farnham, 2018, Genome Biology.

Using 3D epigenomic maps of primary olfactory neuronal cells from living individuals to understand gene regulation

B. Berman, P. Farnham, J. Knowles, 2018, Science Advances.

Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes

Lijing Yao, Benjamin P Berman, B. Berman, 2014, Genome Biology.

Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits

G. Coetzee, P. Laird, P. Farnham, 2016, Epigenetics & Chromatin.

Perspectives on ENCODE

Xintao Wei, Christopher B. Burge, Jason Liu, 2020, Nature.

Histone Modification and Breast Cancer

Xuegang Luo, Yu Guo, Shu Guo, 2011 .

CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops

G. Coetzee, P. Farnham, S. Rhie, 2018, Genome Biology.